Vanda Pharmaceuticals (VNDA) Operating Leases (2019 - 2025)
Historic Operating Leases for Vanda Pharmaceuticals (VNDA) over the last 7 years, with Q4 2025 value amounting to $12.6 million.
- Vanda Pharmaceuticals' Operating Leases rose 211.97% to $12.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.6 million, marking a year-over-year increase of 211.97%. This contributed to the annual value of $12.6 million for FY2025, which is 211.97% up from last year.
- Latest data reveals that Vanda Pharmaceuticals reported Operating Leases of $12.6 million as of Q4 2025, which was up 211.97% from $3.4 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Operating Leases registered a high of $12.6 million during Q4 2025, and its lowest value of $3.4 million during Q3 2025.
- For the 5-year period, Vanda Pharmaceuticals' Operating Leases averaged around $8.6 million, with its median value being $9.1 million (2022).
- In the last 5 years, Vanda Pharmaceuticals' Operating Leases skyrocketed by 3143.34% in 2024 and then plummeted by 3767.77% in 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Operating Leases (Quarter) stood at $12.4 million in 2021, then decreased by 9.91% to $11.1 million in 2022, then decreased by 15.59% to $9.4 million in 2023, then surged by 31.43% to $12.4 million in 2024, then increased by 2.12% to $12.6 million in 2025.
- Its Operating Leases stands at $12.6 million for Q4 2025, versus $3.4 million for Q3 2025 and $3.9 million for Q2 2025.